1 Reason Why Shares of Regeneron Pharmaceuticals Are Surging This Month

Key Points Regeneron Pharmaceuticals is a leading biotech focused on gene editing. While the S&P 500 has dipped lower in November, Regeneron stock has climbed steadily higher. Despite its recent rise, Regeneron remains a valid option for biotech investors. 10 stocks we like better than Regeneron Pharmaceuticals › After climbing 2.3% in October, the S&P 500 has taken a U-turn and driven steadily lower over the past few weeks. From the start of November through Nov. 21, the index has dipped about 3 ...